Enter your terms above and click the 'Search' button.

Showing articles 0 to 12 of 12 Filter Applied: patent foramen ovale,surgical treatment of (Click to remove) Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence Stroke 55:236-247, Sposato,L.A.,et al, 2024 Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention Neurol 94:876-885, Messe, S.R.,et al, 2020 Evidence-Based Management of Patent Foramen Ovale in Patients with Ischemic Stroke JAMA Neurol 75:147-148, Kamel, H., 2018 Patent Foramen Ovale Closure, Antiplatelet Therapy or Anticoagulation Therapy Alone for Management of Cryptogenic Stroke? BMJ 362:k2515, Kuijpers, T.,et al, 2018 Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke NEJM 377:1022-1032,1006,1093, Saver, J.L.,et al, 2017 Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017 Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013 Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism NEJM 368:1083-1091,1152, Meier, B.,et al, 2013 Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention Stroke 43:422-431, Kitsios,G.D.,et al, 2012 Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012 Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004 Practice Parameter: Recurrent Stroke with Patent Foramen Ovale and Atrial Septal Aneurysm Neurol 62:1042-1050, Messe,S.R.,et al, 2004 Showing articles 0 to 12 of 12